Intuitive CEO Gary Guthart to step down after 15 years

Dave Rosa, Intuitive Surgical’s president, takes over as chief executive, as the surgical robot maker accelerates the rollout of its latest da Vinci system.

By Susan Kelly • May 15, 2025

AdvaMed CEO Scott Whitaker pleads for tariff relief in Senate hearing

Whitaker repeated a call for “zero-for-zero” reciprocal tariffs between the U.S. and its trade partners in testimony before a Senate Finance Committee panel on critical supply chains.

By Susan Kelly • May 14, 2025

Explore the Trendline➔

New medical devices are reshaping the medtech industry

From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

By MedTech Dive staff

European Commission readies countermeasures to US tariffs

The commission is taking steps to target roughly $107 billion worth of imports if it can’t make a tariff deal with the U.S.

By Antone Gonsalves • May 14, 2025

Philips taps Nvidia to build AI model for MRI

Philips wants to create a foundation model for MRI to address challenges that are specific to the imaging technique.

By Nick Paul Taylor • May 14, 2025

Embecta restructures again, outlines tariff costs

The diabetes tech company announced a second restructuring after ending its insulin patch-pump program.

By Elise Reuter • May 13, 2025

Vicarious Surgical, UMass partner; SS Innovations targets de novo submission

Vicarious Surgical and SS Innovations marked progress toward bringing their robotic surgery systems to the U.S. market. The companies are among a new generation of robot developers planning to challenge Intuitive Surgical.

By Susan Kelly • May 13, 2025

Teal wins FDA approval for at-home cervical cancer screening device

The company plans to start shipping the device in June, starting in California and then expanding nationwide.

By Nick Paul Taylor • May 13, 2025

Roche plans $550M expansion of Indianapolis site to manufacture CGMs

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its sensors.

By Elise Reuter • May 12, 2025

US, China agree to reduce tariff rates for 90 days

By Wednesday, the two countries will charge 10% baseline duties during the period and remove certain retaliatory levies that pushed rates over 100%.

By Phil Neuffer • May 12, 2025

Solventum’s projected $100M tariff hit prevents earnings increase

CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its supply chains.

By Nick Paul Taylor • May 12, 2025

New Insulet CEO Ashley McEvoy sets priorities

The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.

By Elise Reuter • May 9, 2025

SEC ends probe of Illumina’s Grail acquisition

The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

By Susan Kelly • May 9, 2025

FDA, aiming to speed scientific reviews, names chief AI officer

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA scientists spend less time on repetitive tasks.

By Susan Kelly • May 9, 2025

ADA’s Osagie Ebekozien on diabetes tech for Type 2, new CGM standards

Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices authorized for Type 2 diabetes.

By Elise Reuter • May 9, 2025

Bausch + Lomb receives CE mark for Luxlife intraocular lens

The company plans to launch the lens, which supports vision at all distances, in Europe in the coming weeks.

By Nick Paul Taylor • May 9, 2025

US, UK reach deal on tariffs, market access

The deal includes a reduced tariff for some U.K. automobiles and is the first the Trump administration has secured after unveiling its reciprocal tariff plan in April.

By Phil Neuffer • May 8, 2025

Masimo says cyberattack has impacted its ability to fulfill orders

The maker of patient monitoring devices is working to bring the affected portions of its network back online and restore normal business operations.

By David Jones • May 8, 2025

Siemens Healthineers lowers earnings forecast on expected tariff hit

The company expects a tariff impact of up to 300 million euros, with the biggest hit from European goods going to the U.S.

By Nick Paul Taylor • May 8, 2025

Masimo finds buyer for consumer audio business

In addition to offloading the Sound United segment for $350 million, the company lowered its 2025 profit forecast to account for tariffs.

By Susan Kelly • May 7, 2025

AdvaMed calls for ‘zero for zero’ medtech tariffs between US and UK

AdvaMed and its British counterpart called for urgent action to ensure the situation “does not devolve into a crisis.”

By Nick Paul Taylor • May 7, 2025

RFK’s FDA layoffs could slow safety communications, experts warn

The mass cuts, which included communications staff, could slow public notices on medical device recalls and other safety alerts.

By Elise Reuter • May 6, 2025

Philips cuts earnings forecast after calculating $340M tariff hit

CEO Roy Jakobs said tariff impacts require the company to accelerate localization of production in the U.S.

By Nick Paul Taylor • May 6, 2025

US semiconductor import probe looms over medtech industry

Medical device manufacturers could face increased costs if the Commerce Department's Section 232 probe leads to tariffs on chips.

By Susan Kelly • May 6, 2025

Zimmer Biomet expects $60M to $80M tariff impact this year

The orthopedics company lowered its earnings forecast, accounting for the tariffs and closing the acquisition of Paragon 28.

By Elise Reuter • May 6, 2025

Edwards gains expanded TAVR label for asymptomatic patients

The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement business with more patients becoming eligible for the treatment.

By Susan Kelly • May 5, 2025